Dayanç, Barış Emre

Profile Picture
Profile URL
https://hdl.handle.net/20.500.14365/6927
Name Variants
Dayanc, B. E.
Dayanc, BE
Dayanc, Emre
Dayanc, Baris E.
Dayanc, Baris Emre
Job Title
Email Address
emre.dayanc@ieu.edu.tr
edayanc@mit.edu
Main Affiliation
09.01. Basic Medical Sciences
Status
Current Staff
Website
ORCID ID
0000-0001-7922-1778
Scopus Author ID
23003874000
Turkish CoHE Profile ID
E753F927B94C220C
Google Scholar ID
vLoF9kUAAAAJ
WoS Researcher ID
L-2267-2019
Files
Baris_Emre_Dayanc.png (89.82 KB)

Sustainable Development Goals

NO POVERTY1
NO POVERTY
0
Research Products
ZERO HUNGER2
ZERO HUNGER
0
Research Products
GOOD HEALTH AND WELL-BEING3
GOOD HEALTH AND WELL-BEING
5
Research Products
QUALITY EDUCATION4
QUALITY EDUCATION
0
Research Products
GENDER EQUALITY5
GENDER EQUALITY
0
Research Products
CLEAN WATER AND SANITATION6
CLEAN WATER AND SANITATION
0
Research Products
AFFORDABLE AND CLEAN ENERGY7
AFFORDABLE AND CLEAN ENERGY
0
Research Products
DECENT WORK AND ECONOMIC GROWTH8
DECENT WORK AND ECONOMIC GROWTH
0
Research Products
INDUSTRY, INNOVATION AND INFRASTRUCTURE9
INDUSTRY, INNOVATION AND INFRASTRUCTURE
1
Research Products
REDUCED INEQUALITIES10
REDUCED INEQUALITIES
0
Research Products
SUSTAINABLE CITIES AND COMMUNITIES11
SUSTAINABLE CITIES AND COMMUNITIES
0
Research Products
RESPONSIBLE CONSUMPTION AND PRODUCTION12
RESPONSIBLE CONSUMPTION AND PRODUCTION
0
Research Products
CLIMATE ACTION13
CLIMATE ACTION
1
Research Products
LIFE BELOW WATER14
LIFE BELOW WATER
0
Research Products
LIFE ON LAND15
LIFE ON LAND
0
Research Products
PEACE, JUSTICE AND STRONG INSTITUTIONS16
PEACE, JUSTICE AND STRONG INSTITUTIONS
0
Research Products
PARTNERSHIPS FOR THE GOALS17
PARTNERSHIPS FOR THE GOALS
0
Research Products
Documents

9

Citations

557

h-index

6

Go to Scopus profile
Documents

13

Citations

517

Go to WoS profile
Scholarly Output

7

Articles

5

Views / Downloads

44/166

Supervised MSc Theses

1

Supervised PhD Theses

0

WoS Citation Count

28

Scopus Citation Count

27

Patents

0

Projects

1

WoS Citations per Publication

4.00

Scopus Citations per Publication

3.86

Open Access Source

5

Supervised Theses

1

JournalCount
Turkish Journal of Biology2
European Journal of Immunology1
Expert Reviews in Molecular Medicine1
Internatıonal Journal of Pharmacology1
Journal of Cancer1
Current Page: 1 / 1

Scopus Quartile Distribution

Competency Cloud

GCRIS Competency Cloud

Filters

2017 - 201912020 - 20256
Reset filters

Settings

Scholarly Output Search Results

Now showing 1 - 7 of 7
  • Thumbnail Image
    Article
    Citation - WoS: 26
    Citation - Scopus: 25
    A Combined Ulbp2 and Sema5a Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer
    (Ivyspring Int Publ, 2017) Demirkol, Secil; Gomceli, Ismail; Isbilen, Murat; Dayanc, Baris Emre; Tez, Mesut; Bostanci, Erdal Birol; Turhan, Nesrin
    Background: Prognostic biomarkers for cancer have the power to change the course of disease if they add value beyond known prognostic factors, if they can help shape treatment protocols, and if they are reliable. The aim of this study was to identify such biomarkers for colon cancer and to understand the molecular mechanisms leading to prognostic stratifications based on these biomarkers. Methods and Findings: We used an in house R based script (SSAT) for the in silico discovery of stage-independent prognostic biomarkers using two cohorts, GSE17536 and GSE17537, that include 177 and 55 colon cancer patients, respectively. This identified 2 genes, ULBP2 and SEMA5A, which when used jointly, could distinguish patients with distinct prognosis. We validated our findings using a third cohort of 48 patients ex vivo. We find that in all cohorts, a combined ULBP2/SEMA5A classification (SU-GIB) can stratify distinct prognostic sub-groups with hazard ratios that range from 2.4 to 4.5 (p <= 0.01) when overall-or cancer-specific survival is used as an end-measure, independent of confounding prognostic parameters. In addition, our preliminary analyses suggest SU-GIB is comparable to Oncotype DX colon (R) in predicting recurrence in two different cohorts (HR: 1.5-2; p <= 0.02). SU-GIB has potential as a companion diagnostic for several drugs including the PI3K/mTOR inhibitor BEZ235, which are suitable for the treatment of patients within the bad prognosis group. We show that tumors from patients with worse prognosis have low EGFR autophosphorylation rates, but high caspase 7 activity, and show upregulation of pro-inflammatory cytokines that relate to a relatively mesenchymal phenotype. Conclusions: We describe two novel genes that can be used to prognosticate colon cancer and suggest approaches by which such tumors can be treated. We also describe molecular characteristics of tumors stratified by the SU-GIB signature.
  • Thumbnail Image
    Article
    Citation - WoS: 1
    Citation - Scopus: 1
    Classification of Colon Cancer Patients Into Consensus Molecular Subtypes Using Support Vector Machines
    (TUBITAK, 2023-12-28) Kochan, Necla; Dayanç, Barış Emre
    Background/aim: The molecular heterogeneity of colon cancer has made classification of tumors a requirement for effective treatment. One of the approaches for molecular subtyping of colon cancer patients is the consensus molecular subtypes (CMS), developed by the Colorectal Cancer Subtyping Consortium. CMS-specific RNA-Seq-dependent classification approaches are recent, with relatively low sensitivity and specificity. In this study, we aimed to classify patients into CMS groups using their RNA-seq profiles. Materials and methods: We first identified subtype-specific and survival-associated genes using the Fuzzy C-Means algorithm and log-rank test. We then classified patients using support vector machines with backward elimination methodology. Results: We optimized RNA-seq-based classification using 25 genes with a minimum classification error rate. In this study, we reported the classification performance using precision, sensitivity, specificity, false discovery rate, and balanced accuracy metrics. Conclusion: We present a gene list for colon cancer classification with minimum classification error rates and observed the lowest sensitivity but the highest specificity with CMS3-associated genes, which significantly differed due to the low number of patients in the clinic for this group. © TÜBİTAK.
  • Thumbnail Image
    Conference Object
    Discovery of Subtype Specific Markers Through Fuzzy Logic and Non-Parametric Approaches Using Transcriptomic Data in Immune Related Colon Cancer
    (Wiley, 2021) Kochan, Necla; Dayanç, Barış Emre; Dayanc, Emre
    [Abstract Not Available]
  • Thumbnail Image
    Article
    Cholinergic Receptor Binding Profile of Hypericum Perforatum L. and Its Active Constituents
    (Asian Network Scientific Information-Ansinet, 2022-09-15) Hamurtekin, Emre; Hamurtekin, Y.; Matucci, R.; Dei, S.; Dayanç, Barış Emre; Kazdağlı, Hasan; Baris, E.
    Background andObjective: Hypericum perforatum L (HP) is a popular herbal medicine with different pharmacological effects. This study investigated the possible cholinergic receptor affinities of HP extract and its three active constituents: hyperforin, hypericin and pseudohypericin. Materials and Methods: Radioactive compounds [3H]-N-methyl scopolamine used for muscarinic receptor binding studies in Chinese hamster ovary cells expressing human muscarinic receptor subtypes and [3H]-cytisine used for nicotinic receptor binding tests performed with mouse brains without a cerebellum. Muscarinic binding inhibition was observed with HP extract considerably for hM2 and hM5. Results: Hyperforin, hypericin and pseudohypericin showed a much lower affinity for muscarinic receptors at higher concentrations. The HP extract and its constituents did not produce any nicotinic receptor binding inhibition. Conclusion:These results suggested that post-junctional direct muscarinic receptor interaction may modulate some effects of HP extract and its constituents however different mechanisms apart from direct cholinergic receptor interaction might be considered for the pharmacological actions of hyperforin, hypericin and pseudohypericin.
  • Thumbnail Image
    Master Thesis
    Kalp ve Damar Cerrahisi Yoğun Bakım Ünitesinde Santral Venöz Kateter Bakımı Uygulamalarının Hasta Bağışıklık Sistemi Hücre Sayıları Üzerine Etkisi
    (İzmir Ekonomi Üniversitesi, 2021) Eröz, Derya; Dayanç, Barış Emre; İntepeler, Şeyda Seren
    Santral venöz kateterizasyon, klinikte kritik hastaların sıvı tedavisinde, ilaç uygulamalarında, kan, total parenteral nütrisyon (TPN) verilmesinde ve hemodinamik durumun izleminde kullanılmaktadır. Bu çalışmada kalp-damar cerrahisi yoğun bakım ünitesinde yatan; açık kalp ameliyatı olmuş, santral venöz kateteri olan yetişkin hastalarda, santral kateter bakımı uygulamalarının hasta bağışıklık sistemi hücre sayıları üzerine etkisi incelenmiştir. Santral venöz kateter (SVK) Önlem Paketi (ÖP) uygulanan ve uygulanmayan olmak üzere hastaların, rutin alınan kan tahlillerinden preop, postop 1 ve postop 2. günlerindeki Beyaz kan hücreleri (WBC), Nötrofil, Lenfosit, Monosit, Eozinofil, Bazofil) değerleri karşılaştırılmıştır. SVK Ö.P. uygulanmayan 39, SVK Ö.P. uygulanan 101 hasta bulunmaktadır. Preoperatif immün sistem hastalığı (ör. İmmün yetmezlik veya otoimmün hastalık tanısı), enfeksiyöz hastalığı, onkolojik tanısı olan hastalar çalışmanın dışında bırakılmıştır. SVK Ö.P. uygulamasıyla, santral venöz kateter bakımına bağlı immün değişikliklerin gözlenmesine yönelik kanıta dayalı veri oluşturulmuştur. Önlem paketi uygulanan hastaların preop, postop 1 ve postop 2. gün verileri önlem paketi uygulanmayan hastaların sonuçları ile karşılaştırıldığında, grupların kendi içindeki total lökosit, nötrofil, lenfosit, bazofil, monosit ve eozinofil sayıları açısından değişimler anlamlı iken; gruplar arasında anlamlı bir fark saptanmamıştır (p>0.05). Sonuç olarak SVK önlem paketi uygulamasının, immun hücre sayılarını etkilemediği gözlenmiştir.
  • Thumbnail Image
    Article
    Classification of Colon Cancer Patients Into Consensus Molecular Subtypes Using Support Vector Machines
    (2023-12-28) Koçhan, Necla; Dayanç, Barış Emre
    Background/aim: The molecular heterogeneity of colon cancer has made classification of tumors a requirement for effective treatment. One of the approaches for molecular subtyping of colon cancer patients is the consensus molecular subtypes (CMS), developed by the Colorectal Cancer Subtyping Consortium. CMS-specific RNA-Seq-dependent classification approaches are recent, with relatively low sensitivity and specificity. In this study, we aimed to classify patients into CMS groups using their RNA-seq profiles. Materials and methods: We first identified subtype-specific and survival-associated genes using the Fuzzy C-Means algorithm and log- rank test. We then classified patients using support vector machines with backward elimination methodology. Results: We optimized RNA-seq-based classification using 25 genes with a minimum classification error rate. In this study, we reported the classification performance using precision, sensitivity, specificity, false discovery rate, and balanced accuracy metrics. Conclusion: We present a gene list for colon cancer classification with minimum classification error rates and observed the lowest sensitivity but the highest specificity with CMS3-associated genes, which significantly differed due to the low number of patients in the clinic for this group.
  • Thumbnail Image
    Article
    Citation - WoS: 1
    Citation - Scopus: 1
    Novel Approach Methodologies in Modeling Complex Bioaerosol Exposure in Asthma and Allergic Rhinitis Under Climate Change
    (Cambridge Univ Press, 2025) Atalay-Sahar, Esra; Yildiz-Ozturk, Ece; Ozgur, Su; Aral, Arzu; Dayanc, Emre; Goksel, Tuncay; Goksel, Ozlem
    The undeniable impact of climate change and air pollution on respiratory health has led to increasing cases of asthma, allergic rhinitis and other chronic non-communicable immune-mediated upper and lower airway diseases. Natural bioaerosols, such as pollen and fungi, are essential atmospheric components undergoing significant structural and functional changes due to industrial pollution and atmospheric warming. Pollutants like particulate matter(PMx), polycyclic aromatic hydrocarbons(PAHs), nitrogen dioxide(NO2), sulfur dioxide(SO2) and carbon monoxide(CO) modify the surface and biological properties of atmospheric bioaerosols such as pollen and fungi, enhancing their allergenic potentials. As a result, sensitized individuals face heightened risks of asthma exacerbation, and these alterations likely contribute to the rise in frequency and severity of allergic diseases. NAMs, such as precision-cut lung slices(PCLS), air-liquid interface(ALI) cultures and lung-on-a-chip models, along with the integration of data from these innovative models with computational models, provide better insights into how environmental factors influence asthma and allergic diseases compared to traditional models. These systems simulate the interaction between pollutants and the respiratory system with higher precision, helping to better understand the health implications of bioaerosol exposure. Additionally, NAMs improve preclinical study outcomes by offering higher throughput, reduced costs and greater reproducibility, enhancing the translation of data into clinical applications. This review critically evaluates the potential of NAMs in researching airway diseases, with a focus on allergy and asthma. It highlights their advantages in studying the increasingly complex structures of bioaerosols under conditions of environmental pollution and climate change, while also addressing the existing gaps, challenges and limitations of these models.